PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Longboard Pharmaceuticals, Inc. (LBPH)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US54300N1037

CUSIP

54300N103

Sector

Healthcare

IPO Date

Mar 12, 2021

Highlights

Market Cap

$2.34B

EPS (TTM)

-$2.25

Gross Profit (TTM)

-$3.00K

EBITDA (TTM)

-$71.87M

Year Range

$15.64 - $60.03

Target Price

$64.00

Short %

6.53%

Short Ratio

1.27

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
LBPH vs. SPY LBPH vs. UPRO LBPH vs. PTF
Popular comparisons:
LBPH vs. SPY LBPH vs. UPRO LBPH vs. PTF

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Longboard Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%AugustSeptemberOctoberNovemberDecember
56.36%
8.35%
LBPH (Longboard Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Returns By Period

Longboard Pharmaceuticals, Inc. had a return of 0.00% year-to-date (YTD) and 164.70% in the last 12 months.


LBPH

YTD

0.00%

1M

0.00%

6M

56.36%

1Y

164.70%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

0.62%

1M

-1.93%

6M

5.98%

1Y

23.72%

5Y*

12.67%

10Y*

11.33%

*Annualized

Monthly Returns

The table below presents the monthly returns of LBPH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024252.24%4.43%-2.61%-1.39%-11.41%43.24%22.97%8.54%-7.62%79.18%0.44%894.69%
202330.67%18.78%-20.75%106.48%-16.30%5.92%-1.91%-19.58%-3.97%-2.61%-30.56%60.37%84.97%
2022-13.93%9.29%16.34%-9.49%6.35%-39.88%8.74%-0.30%11.04%-0.54%45.14%-39.29%-33.20%
2021-1.62%-41.82%-13.33%10.41%-1.32%4.22%-5.65%-15.82%-24.90%-12.78%-70.69%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 99, LBPH is among the top 1% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of LBPH is 9999
Overall Rank
The Sharpe Ratio Rank of LBPH is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of LBPH is 100100
Sortino Ratio Rank
The Omega Ratio Rank of LBPH is 9999
Omega Ratio Rank
The Calmar Ratio Rank of LBPH is 100100
Calmar Ratio Rank
The Martin Ratio Rank of LBPH is 100100
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Longboard Pharmaceuticals, Inc. (LBPH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for LBPH, currently valued at 3.57, compared to the broader market-4.00-2.000.002.003.571.92
The chart of Sortino ratio for LBPH, currently valued at 10.37, compared to the broader market-4.00-2.000.002.004.0010.372.57
The chart of Omega ratio for LBPH, currently valued at 2.34, compared to the broader market0.501.001.502.002.341.35
The chart of Calmar ratio for LBPH, currently valued at 16.18, compared to the broader market0.002.004.006.0016.182.86
The chart of Martin ratio for LBPH, currently valued at 69.96, compared to the broader market-10.000.0010.0020.0069.9612.10
LBPH
^GSPC

The current Longboard Pharmaceuticals, Inc. Sharpe ratio is 3.57. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Longboard Pharmaceuticals, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio1.002.003.004.005.00AugustSeptemberOctoberNovemberDecember
3.57
2.34
LBPH (Longboard Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Longboard Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember0
-0.64%
LBPH (Longboard Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Longboard Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Longboard Pharmaceuticals, Inc. was 82.95%, occurring on Jul 1, 2022. Recovery took 377 trading sessions.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-82.95%Apr 7, 2021313Jul 1, 2022377Jan 2, 2024690
-34.77%Jan 24, 202459Apr 17, 202450Jun 28, 2024109
-30.18%Jul 17, 202444Sep 17, 202419Oct 14, 202463
-10.76%Jan 3, 20241Jan 3, 20242Jan 5, 20243
-10.08%Jan 8, 20243Jan 10, 20248Jan 23, 202411

Volatility

Volatility Chart

The current Longboard Pharmaceuticals, Inc. volatility is 0.32%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%AugustSeptemberOctoberNovemberDecember
0.32%
2.43%
LBPH (Longboard Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Longboard Pharmaceuticals, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Longboard Pharmaceuticals, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab